Rankings
▼
Calendar
NAGE FY 2014 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena
NAGE
Niagen Bioscience Inc
$392M
FY 2014 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$15M
+50.7% YoY
Gross Profit
$5M
34.8% margin
Operating Income
-$5M
-34.2% margin
Net Income
-$5M
-35.2% margin
EPS (Diluted)
$-0.15
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$12M
Total Liabilities
$8M
Stockholders' Equity
$4M
Cash & Equivalents
$4M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$15M
$10M
+50.7%
Gross Profit
$5M
$3M
+70.0%
Operating Income
-$5M
-$4M
-19.3%
Net Income
-$5M
-$4M
-21.9%
← FY 2013
All Quarters
FY 2015 →